AKR1C3 and prostate cancer: The AKR1C3 gene, also known as type 5, 17β-hydroxysteroid dehydrogenase (17β-HSD), is a key enzyme in the last two steps of testosterone and DHT synthesis in tumor cells (19, 20), with DHT deemed to promote the growth, proliferation, and metastasis of prostate cancer cells.